Neuroligin |
dnl1 deletion |
Not tested |
Decreased stimulus evoked transmitter release, no change in quantal size |
Decrease in number of synaptic boutons, immature postsynaptic apparatus, misalignment of pre- and postsynaptic specialisation |
[34] |
dnl2 deletion |
Reduced larval locomotion |
Increased stimulus evoked transmitter release, decreased paired pulse plasticity, no change in quantal size |
Decrease in number of synaptic boutons, increased density of active zones per bouton, immature postsynaptic apparatus, decrease in GluR density, increase in ratio of A-type to B-type GluRs, increased length of PSD |
[35] |
Neurexin |
dnrx deletion |
Reduced larval locomotion, defect in associative learning in larvae, shortened life span |
Decreased stimulus evoked transmitter release, decreased synaptic vesicle recycling, defective calcium sensitivity of evoked transmitter release |
Reduced synapse number in CNS and at NMJ, increased density of active zones per bouton at NMJ, increased size of PSD, increase ratio of A-type to B-type GluR receptors in embryonic NMJs |
[26, 27, 70, 91] |
Neurexin–neuroligin double mutants |
dnrx/dnl1
|
Not tested |
Not tested |
Defects in synaptic boutons no worse than in dnl1 mutants, dnl1
D356R rescued phenotype in dnl1 mutant background but does not show dominant negative phenotype like wild type when overexpressed |
[34] |
dnrx/dnl2
|
More severe defect in locomotion than either dnl2 or dnrx
|
Not tested |
Lethal at late 2nd instar larval stage. More severe defect in NMJ morphology in both double homozygous early 2nd instar larvae, and hemizygous 3rd instar larvae. Dnl2 shown to exist in complex with Dnrx in vivo |
[35] |